Senior insider sale
Chief Development Officer at OCULAR THERAPEUTIX, INC — senior position signals high conviction
$57.0K
6K shares
What this filing means
KAISER PETER plans to sell 6K shares of OCULAR THERAPEUTIX, INC valued at approximately $57.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/24/2026ACC: 0001950047-26-008627
Officer· Chief Development Officer
Since Feb 2026
6K
Shares to sell
$57.0K
Approx. market value
3.04K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting Under a Registered Plan
Not Applicable
8/22/2026
3.04KTotal acquired3.04K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/22/2026 | Restricted Stock Vesting Under a Registered Plan Not Applicable | 3.04K | — |
| Total | 3.04K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.97K
Market value
$24.3K
5/26/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.04K
Market value
$32.7K
8/24/2026
Total
Units
6K
Value
$57.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/26/2026 | 2.97K | $24.3K | — | Completed |
| Planned — Approximate Date | ||||
8/24/2026 | 3.04K | $32.7K | NASDAQ | Planned |
| Total | 6K | $57.0K | ||